Skip to main content
. 2018 Apr 27;9:451. doi: 10.3389/fphys.2018.00451

Figure 3.

Figure 3

Osmoscan profile in splenectomized patients. (A) Shaded area = control range curve; Dashed area = splenectomised patients (seven affected by PKD, two by Pyr5′N deficiency and seven by CDAII); (B) CDAII: non-splenectomised (Inline graphic), splenectomised (Inline graphic); (C) PKD: non-splenectomised (Inline graphic), splenectomised (Inline graphic); (D) Pyr5′N deficiency: non-splenectomised (Inline graphic), splenectomised (Inline graphic).